Clinical trials
Completed Obesity trials in Slovakia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2022 | 2 |
| 2023 | 6 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novo Nordisk A/S | 4 |
| Boehringer Ingelheim | 2 |
| Eli Lilly and Company | 2 |
| Novartis Pharmaceuticals | 1 |
| Sigrid Therapeutics AB | 1 |
| Slovak Academy of Sciences | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 11 |
| Diabetes Mellitus, Type 2 | 4 |
| Overweight | 4 |
| Cardiovascular Diseases | 2 |
| Renal Insufficiency, Chronic | 2 |
| Liver Diseases | 1 |
| Metabolic Syndrome | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.